ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,406,835 | -11.4% | 530,834 | +0.4% | 0.01% | -13.3% |
| Q2 2023 | $16,260,015 | -15.8% | 528,953 | -1.3% | 0.02% | -16.7% |
| Q1 2023 | $19,310,891 | -10.1% | 535,967 | -1.4% | 0.02% | -14.3% |
| Q4 2022 | $21,477,579 | -0.9% | 543,461 | +0.8% | 0.02% | -8.7% |
| Q3 2022 | $21,663,000 | -4.4% | 539,143 | +0.0% | 0.02% | 0.0% |
| Q2 2022 | $22,661,000 | +51.1% | 539,034 | +40.1% | 0.02% | +76.9% |
| Q1 2022 | $14,994,000 | +2985.2% | 384,844 | +3748.4% | 0.01% | +1200.0% |
| Q2 2020 | $486,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |